SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divis Laboratories informs about board meeting

23 Jan 2017 Evaluate

Divis Laboratories has informed that a meeting of Board of Directors of the Company is scheduled to be held on February 04, 2017, to consider and approve the un-audited financial results for the quarter and nine months ended December 31, 2016(Q3). Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from January 28, 2017 to February 06, 2017 as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Divis Laboratories Share Price

7258.05 -61.70 (-0.84%)
17-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1933.10
Dr. Reddys Labs. 1210.85
Cipla 1418.40
Lupin 2442.10
Zydus Lifesciences 1142.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: